FURX Share Price

Open 106.28 Change Price %
High 106.68 1 Day -1.41 -1.33
Low 104.77 1 Week 0.00 0.00
Close 104.77 1 Month 0.00 0.00
Volume 1141373 1 Year 0.00 0.00
52 Week High 7.17
52 Week Low 0.00
FURX Important Levels
Resistance 2 106.54
Resistance 1 105.81
Pivot 105.41
Support 1 103.73
Support 2 103.00
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.67 0.17%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OPXAW 0.01 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

Furiex Pharmaceuticals, Inc. (NASDAQ: FURX)

FURX Technical Analysis 5
As on 1st Jul 2014 FURX Share Price closed @ 104.77 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 66.33 & Strong Buy for SHORT-TERM with Stoploss of 100.10 we also expect STOCK to react on Following IMPORTANT LEVELS.
FURX Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
FURX Other Details
Segment EQ
Market Capital 195298288.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.furiex.com
FURX Address
FURX
3900 Paramount Parkway
Suite 150
Morrisville, NC 27560
United States
Phone: 919-456-7800
FURX Latest News
Interactive Technical Analysis Chart Furiex Pharmaceuticals, Inc. ( FURX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Furiex Pharmaceuticals, Inc.
FURX Business Profile
Furiex Pharmaceuticals, Inc. is a drug development collaboration company. The Company�s product pipeline includes two marketed products and three programs in development, including late-stage compounds, in multiple therapeutic areas. Its programs include Priligy, Alogliptin Nesina, Alogliptin/Actose Combination, Alogliptin/Metformin Combination, Fluoroquinolone, Mu Delta and PPD 10558. Priligy (dapoxetine) is a drug developed for the on-demand treatment of premature ejaculation (PE). Dapoxetine is a short-acting, selective serotonin reuptake inhibitor (SSRI) designed to be taken only when needed one to three hours before sexual intercourse is anticipated rather than every day. Nesina (alogliptin) is a drug for the oral treatment of type 2 diabetes (T2D). In November 2011, it acquired full exclusive license rights to develop and commercialize the compound MuDelta under its existing development and license agreement with Janssen Pharmaceutica N.V.